Publications by authors named "Keyvan Fallah-Mehrjardi"

Claim this Profile
M
MicroRNA-124 Enhances T Cells Functions by Manipulating the Lactic Acid Metabolism of Tumor Cells.
Mohammad Khakpoor-Koosheh, Hosein Rostamian, Elham Masoumi, Leila Jafarzadeh, Keyvan Fallah-Mehrjardi

Iran J Allergy Asthma Immunol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restricting tumor lactic acid metabolism using dichloroacetate improves T cell functions.
Hosein Rostamian, Mohammad Khakpoor-Koosheh, Leila Jafarzadeh, Elham Masoumi, Keyvan Fallah-Mehrjardi

BMC Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted knockdown of Tim3 by short hairpin RNAs improves the function of anti-mesothelin CAR T cells.
Leila Jafarzadeh, Elham Masoumi, Hamid Reza Mirzaei, Khadijeh Alishah, Keyvan Fallah-Mehrjardi

Mol Immunol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondria as Playmakers of CAR T-cell Fate and Longevity.
Hosein Rostamian, Mohammad Khakpoor-Koosheh, Keyvan Fallah-Mehrjardi, Hamid R Mirzaei, Christine E Brown

Cancer Immunol Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged Persistence of Chimeric Antigen Receptor (CAR) T Cell in Adoptive Cancer Immunotherapy: Challenges and Ways Forward.
Leila Jafarzadeh, Elham Masoumi, Keyvan Fallah-Mehrjardi, Hamid Reza Mirzaei, Jamshid Hadjati

Front Immunol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A metabolic switch to memory CAR T cells: Implications for cancer treatment.
Hosein Rostamian, Keyvan Fallah-Mehrjardi, Mohammad Khakpoor-Koosheh, John M Pawelek, Jamshid Hadjati

Cancer Lett· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological targeting of immune checkpoint A2aR improves function of anti-CD19 CAR T cells in vitro.
Keyvan Fallah-Mehrjardi, Hamid Reza Mirzaei, Elham Masoumi, Leila Jafarzadeh, Hosein Rostamian

Immunol Lett· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construction and Functional Characterization of a Fully Human Anti-mesothelin Chimeric Antigen Receptor (CAR) Expressing T Cell.
Leila Jafarzadeh, Elham Masoumi, Khadijeh Alishah, Hamid Reza Mirzaei, Arezoo Jamali, Keyvan Fallah-Mehrjardi

Iran J Allergy Asthma Immunol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic and pharmacological targeting of A2a receptor improves function of anti-mesothelin CAR T cells.
Elham Masoumi, Leila Jafarzadeh, Hamid Reza Mirzaei, Khadijeh Alishah, Keyvan Fallah-Mehrjardi

J Exp Clin Cancer Res· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoparticle-siRNA: a potential strategy for ovarian cancer therapy?
Shahin Aghamiri, Keyvan Fallah Mehrjardi, Sasan Shabani, Mahsa Keshavarz-Fathi, Saeed Kargar

Nanomedicine (Lond)· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construction and functional characterization of a fully human anti-CD19 chimeric antigen receptor (huCAR)-expressing primary human T cells.
Hamid Reza Mirzaei, Arezoo Jamali, Leila Jafarzadeh, Elham Masoumi, Khadijeh Alishah

J Cell Physiol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis